Effect of ibudilast: a novel antiasthmatic agent, on airway hypersensitivity in bronchial asthma.

Ibudilast, a unique agent with vasodilating and antiallergic actions, was studied in 13 asthmatics for its effect on airway hypersensitivity to histamine inhalation. The PC20 values improved significantly from 355.6 to 620.5 micrograms/ml at 3 months and further to 731.4 micrograms/ml at 6 months following the initial treatment with ibudilast (20 mg twice daily orally). In addition, the severity of the attacks decreased significantly. Improvements in the PC20 and asthmatic symptoms also were observed in the disodium chromoglycate group, but these were equal to or lesser than those in the ibudilast group. No improvement was observed in the untreated control group. These results suggest that ibudilast would be an effective agent for improving nonspecific airway hypersensitivity in asthmatics.

[1]  Y. Mizushima,et al.  Effect of antiallergic agents and bronchial hypersensitivity in short-term bronchial asthma. , 1991, Chest.

[2]  I. Takayanagi,et al.  Antagonistic effect of KC-404, a new anti-asthmatic agent, on leukotriene D4-induced contractile responses in isolated guinea pig smooth muscles. , 1986, Prostaglandins.

[3]  K. Nishino,et al.  A new vasodilator 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine (KC-404) has a dual mechanism of action on platelet aggregation. , 1986, Archives internationales de pharmacodynamie et de therapie.

[4]  K. Sekizawa,et al.  Bronchodilating effect of KC-404, a novel anti-asthmatic agent, and its derivatives in monkey. , 1986, Archives internationales de pharmacodynamie et de therapie.

[5]  K. Nishino,et al.  Mode of cerebral vasodilating action of KC-404 in isolated canine basilar artery. , 1986, Archives internationales de pharmacodynamie et de therapie.

[6]  Y. Maki,et al.  Mechanism of the action of amoxanox (AA-673), an orally active antiallergic agent. , 1985, International archives of allergy and applied immunology.

[7]  T. Irikura,et al.  KC-404: a potential anti-allergic agent with antagonistic action against slow reacting substance of anaphylaxis. , 1983, Japanese journal of pharmacology.

[8]  H. Nagai,et al.  Pharmacological studies on newly synthesized anti-allergic agents, 2-methyl-3-piperidino-beta-propionaphtone hydrochloride (KZ-111) and 3-isobutyryl-2-isopropylpyrazole-[1, 5-a] pyridine (KC-404). , 1983, Japanese journal of pharmacology.

[9]  S. Hata,et al.  ANTIALLERGIC AGENTS. I. PYRANOQUINOLINE DERIVATIVES , 1981 .

[10]  K. Tasaka,et al.  Anti-allergic properties of a new histamine antagonist, 4-(p-chlorobenzyl)-2- [N-methyl-perhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride (azelastine). , 1979, Arzneimittel-Forschung.

[11]  D. Römer,et al.  The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene. , 1978, Arzneimittel-Forschung.

[12]  Y. Yanagihara,et al.  Inhibition of hypersensitivity reactions by a new drug, N(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'). , 1976, The Journal of allergy and clinical immunology.

[13]  J. Cox.  Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen Mechanisms , 1967, Nature.